Suprabasal expression of the human papillomavirus type 16 oncoproteins in mouse epidermis alters expression of cell cycle regulatory proteins

Carcinogenesis

Volumn 21, Issue 5, 2000, Pages 1031-1037

  Crish, James F ^a   Bone, Frederic ^a   Balasubramanian, Sivaprakasam ^a   Zaim, Tarif M ^a   Wagner, Thomas ^b   Yun, Jeung ^b   Rorke, Ellen A ^a   Eckert, Richard L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Edison Biotechnology Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; DNA; ONCOPROTEIN; PROTEIN P21; PROTEIN P27; PROTEIN P53; VIRUS MESSENGER RNA; VIRUS PROTEIN;

ACANTHOSIS; ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CHEEK MUCOSA; CONTROLLED STUDY; DESQUAMATION; DNA SYNTHESIS; EPIDERMIS; KERATINOCYTE; MOUSE; NONHUMAN; PARAKERATOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WART VIRUS;

EID: 0034020641     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.5.1031     Document Type: Article

References (70)

1. zur Hausen, H. (1991) Viruses in human cancers. Science, 254, 1167-1173.
2. zur Hausen, H. (1991) Human papillomaviruses in the pathogenesis of anogenital cancet Virology, 184, 9-13.
3. Vousden, K.H. (1994) Interactions between papillomavirus proteins and tumor suppressor gene products. Adv. Cancer Res., 64, 1-24.
4. Crook, T. and Vousden, K.H. (1994) Interaction of HPV E6 with p53 and associated proteins. Biochem. Soc. Trans., 22, 52-55.
5. Crook, T., Tidy, J.A. and Vousden, K.H. (1991) Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell, 67, 547-556.
6. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J. and Howley, P.M. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-1136.
7. el-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W. and Vogelstein, B. (1993) WAFI, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
8. Grana, X. and Reddy, E.P. (1995) Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene, 11, 211-219.
9. Hunter, T. and Pines, J. (1994) Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age [see comments]. Cell, 79, 573-582.
10. Munger, K., Werness, B.A., Dyson, N., Phelps, W.C., Harlow, E. and Howley, P.M. (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J., 8, 4099-4105.
11. Dyson, N., Howley, P.M., Munger, K. and Harlow, E. (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science, 243, 934-937.
12. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
13. Hatakeyama, M. and Weinberg, R.A. (1995) The role of RB in cell cycle control. Prog. Cell Cycle Res., 1, 9-19.
14. Eckert, R.L. and Rorke, E.A. (1989) Molecular biology of keratinocyte differentiation. Environ. Health Perspect., 80, 109-116.
15. Green, H. (1980) The keratinocyte as differentiated cell type. Harvey Lect., 74, 101-139.
16. Eckert, R.L., Crish, J.F. and Robinson, N.A. (1997) The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol. Rev., 77, 397-424.
17. Eckert, R.L., Crish, J.F., Banks, E.B. and Welter, J.F. (1997) The epidermis: genes on - genes off. J. Invest. Dermatol., 109, 501-509.
18. Lechner, M.S. and Laimins, L.A. (1994) Inhibition of p53 DNA binding by human papillomavirus E6 proteins. J. Virol., 68, 4262-4273.
19. Thomas, J.T. and Laimins, L.A. (1998) Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint. J. Virol., 72, 1131-1137.
20. Ruesch, M.N. and Laimins, L.A. (1997) Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity. J. Virol., 71, 5570-5578.
21. Jones, D.L., Alani, R.M. and Munger, K. (1997) The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev., 11, 2101-2111.
22. McIntyre, M.C., Ruesch, M.N. and Laimins, L.A. (1996) Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. Virology, 215, 73-82.
23. Khleif, S.N., DeGregori, J., Yee, C.L., Otterson, G.A., Kaye, F.J., Nevins, J.R. and Howley, P.M. (1996) Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc. Natl Acad. Sci. USA. 93, 4350-4354.
24. Halbert, C.L., Demers, G.W. and Galloway, D.A. (1992) The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol., 66, 2125-2134.
25. Halbert, C.L., Demers, G.W. and Galloway, D.A. (1991) The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol., 65, 473-478.
26. Cheng, S., Schmidt, G.D., Murant, T., Broker, T.R. and Chow, L.T. (1995) Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev., 9, 2335-2349.
27. Helland, A., Karlsen, F., Due, E.U., Holm, R., Kristensen, G. and Borresen, D.A. (1998) Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load. Br. J. Cancer, 78, 69-72.
28. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature, 227, 680-685.
29. Seedorf, K., Krammer, G., Durst, M., Suhai, S. and Rowekamp, W.G. (1985) Human papillomavirus type 16 DNA sequence. Virology, 145, 181-185.
30. Ellis, L., Clauser, E., Morgan, D.O., Edery, M., Roth, R.A. and Rutter, W.J. (1986) Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell, 45, 721-732.
31. Welter, J.F., Crish, J.F., Agarwal, C. and Eckert, R.L. (1995) Fos-related antigen (Fra-1), junB and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity. J. Biol. Chem., 270, 12614-12622.
32. Welter, J.F., Gali, H., Crish, J.F. and Eckert, R.L. (1996) Regulation of human involucrin promoter activity by POU domain proteins. J. Biol. Chem., 271, 14727-14733.
33. Crish, J.F., Howard, J.M., Zaim, T.M., Murthy, S. and Eckert, R.L. (1993) Tissue-specific and differentiation-appropriate expression of the human involucrin gene in transgenic mice: an abnormal epidermal phenotype. Differentiation, 53, 191-200.
34. Falcinelli, C., Claas, E., Kleter, B. and Quint, W.G. (1992) Detection of the human papilloma virus type 16 mRNA-transcripts in cytological abnormal scrapings. J. Med. Virol., 37, 93-98.
35. Longley, J., Ding, T.G., Cuono, C., Durden, F., Crooks, C., Hufeisen, S., Eckert, R.L. and Wood, G.S. (1991) Isolation, detection and amplification of intact mRNA from dermatome strips, epidermal sheets and sorted epidermal cells. J. Invest. Dermatol., 97, 974-979.
36. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
37. Rohlfs, M., Winkenbach, S., Meyer, S., Rupp, T. and Durst, M. (1991) Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16. Virology, 183, 331-342.
38. Sherman, L., Alloul, N., Golan, I., Durst, M. and Baram, A. (1992) Expression and splicing patterns of human papillomavirus type-16 mRNAs in pre-cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16 and in cell lines established from cervical cancers. Int. J. Cancer. 50, 356-364.
39. Shirasawa, H., Tanzawa, H., Matsunaga, T. and Simizu, B. (1991) Quantitative detection of spliced E6-E7 transcripts of human papillomavirus type 16 in cervical premalignant lesions. Virology, 184, 795-798.
40. Doorbar, J., Parton, A., Hartley, K., Banks, L., Crook, T., Stanley, M. and Crawford, L. (1990) Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology, 178, 254-262.
41. Hsu, E.M. and McNicol, P.J. (1992) Characterization of HPV-16 E6/E7 transcription in CaSki cells by quantitative PCR. Mol Cell. Probes, 6, 459-466.
42. Huibregtse, J.M., Scheffner, M. and Howley, P.M. (1994) E6-AP directs the HPV E6-dependent inactivation of p53 and is representative of a family of structurally and functionally related proteins. Cold Spring Harbor Symp. Quant. Biol., 59, 237-245.
43. Gulliver, G.A., Herber, R.L., Liem, A. and Lambert, P.F. (1997) Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice. J. Virol., 71, 5905-5914.
44. Lambert, P.F., Pan, H., Pitot, H.C., Liem, A., Jackson, M. and Griep, A.E. (1993) Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc. Natl Acad. Sci. USA, 90, 5583-5587.
45. Arbeit, J.M., Howley, P.M. and Hanahan, D. (1996) Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc. Natl Acad. Sci. USA, 93, 2930-2935.
46. Greenhalgh, D.A., Wang, X.J., Rothnagel, J.A., Eckhardt, J.N., Quintanilla, M.I., Barber, J.L., Bundman, D.S., Longley, M.A., Schlegel, R. and Roop, D.R. (1994) Transgenic mice expressing targeted HPV-18 E6 and E7 oncogenes in the epidermis develop verrucous lesions and spontaneous, rasHa-activated papillomas. Cell Growth Differ., 5, 667-675.
47. Tinsley, J.M., Fisher, C. and Searle, P.F. (1992) Abnormalities of epidermal differentiation associated with expression of the human papillomavirus type 1 early region in transgenic mice. J. Gen. Virol., 73, 1251-1260.
48. Stoler, M.H., Wolinsky, S.M., Whitbeck, A., Broker, T.R. and Chow, L.T. (1989) Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology, 172, 331-340.
49. Stoler, M.H., Rhodes, C.R., Whitbeck, A., Wolinsky, S.M., Chow, L.T. and Broker, T.R. (1992) Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol., 23, 117-128.
50. Crish, J.F., Zaim, T. and Eckert, R.L. (1998) The distal regulatory region (DRR) of the human involucrin promoter is required for expression in epidermis. J. Biol Chem., 273, 30460-30465.
51. Rice, R.H. and Green, H. (1979) Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell, 18, 681-694.
52. Murphy, G.F., Flynn, T.C., Rice, R.H. and Pinkus, G.S. (1984) Involucrin expression in normal and neoplastic human skin: a marker for keratinocyte differentiation. J. Invest. Dermatol., 82, 453-457.
53. zur Hausen, H. and Rosl, F. (1994) Pathogenesis of cancer of the cervix. Cold Spring Harbor Symp. Quant. Biol., 59, 623-628.
54. zur Hausen, H. (1994) Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr. Top. Microbiol. Immunol., 186, 131-156.
55. Pirisi, L., Creek, K.E., Doniger, J. and DiPaolo, J.A. (1988) Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA. Carcinogenesis, 9, 1573-1579.
56. DiPaolo, J.A., Woodworth, C.D., Popescu, N.C., Notario, V. and Doniger, J. (1989) Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and the viral Harvey ras. Oncogene. 4, 395-399.
57. DiPaolo, J.A., Popescu, N.C., Alvarez, L. and Woodworth, C.D. (1993) Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. Crit. Rev. Oncog., 4, 337-360.
58. Smotkin, D., Prokoph, H. and Wettstein, F.O. (1989) Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J. Virol., 63, 1441-1447.
59. Forslund, O., Lindqvist, P., Haadem, K., Czegledy, J. and Hansson, B.G. (1997) HPV 16 DNA and mRNA in cervical brush samples quantified by PCR and microwell hybridization. J. Virol. Methods, 69, 209-222.
60. Fujii, T., Tsukazaki, K., Kiguchi, K., Kubushiro, K., Yajima, M. and Nozawa, S. (1995) The major E6/E7 transcript of HPV-16 in exfoliated cells from cervical neoplasia patients. Gynecol. Oncol., 58, 210-215.
61. McNicol, P., Guijon, F., Wayne, S., Hidajat, R. and Paraskevas, M. (1995) Expression of human papillomavirus type 16 E6-E7 open reading frame varies quantitatively in biopsy tissue from different grades of cervical intraepithelial neoplasia. J. Clin. Microbiol., 33, 1169-1173.
62. Stacey, S.N., Jordan, D., Snijders, P.J., Mackett, M., Walboomers, J.M. and Arrand, J.R. (1995) Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame. J. Virol., 69, 7023-7031.
63. Yamada, T., Yamashita, T., Nishikawa, T., Fujimoto, S. and Fujinaga, K. (1995) Biologic activity of human papillomavirus type 16 E6/E7 cDNA clones isolated from SiHa cervical carcinoma cell line. Virus Genes. 10, 15-25.
64. Rose, B.R., Thompson, C.H., Tattersall, M.H., Elliott, P.M., Dalrymple, C. and Cossart, Y.E. (1995) Identification of E6/E7 transcription patterns in HPV 16-positive cervical cancers using the reverse transcription/polymerase chain reaction. Gynecol. Oncol., 56, 239-244.
65. von-Knebel-Doeberitz, M., Rittmuller, C., Aengeneyndt, F., Jansen, D.P. and Spitkovsky, D. (1994) Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. J. Virol., 68, 2811-2821.
66. Frattini, M.G., Lim, H.B., Doorbar, J. and Laimins, L.A. (1997) Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. J. Virol., 71, 7068-7072.
67. Demers, G.W., Foster, S.A., Halbert, C.L. and Galloway, D.A. (1994) Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl Acad. Sci. USA, 91, 4382-4386.
68. Hudson, J.B., Bedell, M.A., McCance, D.J. and Laimims, L.A. (1990) Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J. Virol., 64, 519-526.
69. Snape, A.M., Jonas, E.A. and Sargent, T.D. (1990) KTF-1, a transcriptional activator of Xenopus embryonic keratin expression. Development, 109, 157-165.
70. Ralhan, R., Swain, R.K., Agarwal, S., Kaur, J., Nath, N., Sarkar, G., Mathur, M. and Shukla, N.K. (1999) P-glycoprotein is positively correlated with p53 in human oral pre-malignant and malignant lesions and is associated with poor prognosis. Int. J. Cancer. 84, 80-85.